drugset / Trial / NCT05874310
Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa
Phase 0
Recruiting
18 enrolled
Frontera Therapeutics
Eye & ENT Hospital of Fudan University · collabHenan Provincial People's Hospital · collabPeking Union Medical College Hospital · collab
Non-randomizedSequentialOpen-labelTreatment
Summary
A clinical trial of gene therapy for patients with X-linked retinitis pigmentosa (XLRP).
Timeline
- Start
- 2023-02-01
- Primary completion
- 2023-10-31
- Completion
- 2027-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FT-002 | Gene therapy (AAV / viral vector) | — | Other |